Annual Book Value
$710.40 M
+$125.79 M+21.52%
December 31, 2024
Summary
- As of March 4, 2025, IOVA annual book value is $710.40 million, with the most recent change of +$125.79 million (+21.52%) on December 31, 2024.
- During the last 3 years, IOVA annual book value has risen by +$88.75 million (+14.28%).
- IOVA annual book value is now at all-time high.
Performance
IOVA Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$710.40 M
-$63.05 M-8.15%
December 31, 2024
Summary
- As of March 4, 2025, IOVA quarterly book value is $710.40 million, with the most recent change of -$63.05 million (-8.15%) on December 31, 2024.
- Over the past year, IOVA quarterly book value has stayed the same.
- IOVA quarterly book value is now -8.15% below its all-time high of $773.45 million, reached on September 30, 2024.
Performance
IOVA Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
IOVA Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.5% | 0.0% |
| 3 y3 years | +14.3% | 0.0% |
| 5 y5 years | +137.6% | 0.0% |
IOVA Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.2% | -8.2% | +80.4% |
| 5 y | 5-year | at high | +137.6% | -8.2% | +192.0% |
| alltime | all time | at high | +5658.3% | -8.2% | +4216.2% |
Iovance Biotherapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $710.40 M(+21.5%) | $710.40 M(-8.2%) |
| Sep 2024 | - | $773.45 M(+0.6%) |
| Jun 2024 | - | $768.54 M(+13.0%) |
| Mar 2024 | - | $680.02 M(+16.3%) |
| Dec 2023 | $584.61 M(+17.0%) | $584.61 M(-13.3%) |
| Sep 2023 | - | $674.00 M(+16.5%) |
| Jun 2023 | - | $578.57 M(-13.2%) |
| Mar 2023 | - | $666.88 M(+33.5%) |
| Dec 2022 | $499.63 M(-19.6%) | $499.63 M(+26.9%) |
| Sep 2022 | - | $393.73 M(-16.7%) |
| Jun 2022 | - | $472.69 M(-14.4%) |
| Mar 2022 | - | $551.99 M(-11.2%) |
| Dec 2021 | $621.66 M(-5.3%) | $621.66 M(-11.0%) |
| Sep 2021 | - | $698.33 M(-6.2%) |
| Jun 2021 | - | $744.41 M(+15.0%) |
| Mar 2021 | - | $647.43 M(-1.4%) |
| Dec 2020 | $656.49 M(+119.6%) | $656.49 M(-7.8%) |
| Sep 2020 | - | $711.84 M(-6.1%) |
| Jun 2020 | - | $758.30 M(+211.7%) |
| Mar 2020 | - | $243.31 M(-18.6%) |
| Dec 2019 | $298.97 M(-35.9%) | $298.97 M(-15.8%) |
| Sep 2019 | - | $355.06 M(-10.7%) |
| Jun 2019 | - | $397.42 M(-8.6%) |
| Mar 2019 | - | $434.93 M(-6.7%) |
| Dec 2018 | $466.19 M(+220.5%) | $466.19 M(+83.4%) |
| Sep 2018 | - | $254.15 M(-6.1%) |
| Jun 2018 | - | $270.56 M(-7.5%) |
| Mar 2018 | - | $292.55 M(+101.1%) |
| Dec 2017 | $145.47 M(-12.8%) | $145.47 M(-12.1%) |
| Sep 2017 | - | $165.43 M(+28.1%) |
| Jun 2017 | - | $129.14 M(-13.8%) |
| Mar 2017 | - | $149.88 M(-10.2%) |
| Dec 2016 | $166.91 M | $166.91 M(-6.8%) |
| Sep 2016 | - | $179.12 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $188.93 M(+91.0%) |
| Mar 2016 | - | $98.94 M(-4.9%) |
| Dec 2015 | $104.02 M(+132.0%) | $104.02 M(-4.9%) |
| Sep 2015 | - | $109.37 M(-3.1%) |
| Jun 2015 | - | $112.87 M(+1.1%) |
| Mar 2015 | - | $111.63 M(+148.9%) |
| Dec 2014 | $44.84 M(+154.7%) | $44.84 M(+177.5%) |
| Sep 2014 | - | $16.16 M(-7.0%) |
| Jun 2014 | - | $17.38 M(+3.4%) |
| Mar 2014 | - | $16.81 M(-4.5%) |
| Dec 2013 | $17.60 M(-255.5%) | $17.60 M(-627.0%) |
| Sep 2013 | - | -$3.34 M(+20.5%) |
| Jun 2013 | - | -$2.77 M(-77.4%) |
| Mar 2013 | - | -$12.28 M(+8.5%) |
| Dec 2012 | -$11.32 M(-11.4%) | -$11.32 M(-31.7%) |
| Sep 2012 | - | -$16.58 M(-0.2%) |
| Jun 2012 | - | -$16.62 M(-3.7%) |
| Mar 2012 | - | -$17.26 M(+35.0%) |
| Dec 2011 | -$12.78 M(-2103.0%) | -$12.78 M(+124.6%) |
| Sep 2011 | - | -$5.69 M(+305.3%) |
| Jun 2011 | - | -$1.40 M(-982.4%) |
| Mar 2011 | - | $159.10 K(-75.1%) |
| Dec 2010 | $638.10 K(-4826.7%) | $638.10 K(+42.4%) |
| Sep 2010 | - | $448.00 K(+7.2%) |
| Jun 2010 | - | $418.00 K(-16.6%) |
| Mar 2010 | - | $501.20 K(-3812.6%) |
| Dec 2009 | -$13.50 K(-687.0%) | -$13.50 K(+21.6%) |
| Sep 2009 | - | -$11.10 K(+44.2%) |
| Jun 2009 | - | -$7700.00(+79.1%) |
| Mar 2009 | - | -$4300.00(-287.0%) |
| Dec 2008 | $2300.00 | $2300.00(-86.1%) |
| Sep 2008 | - | $16.60 K(-13.1%) |
| Jun 2008 | - | $19.10 K(-44.0%) |
| Mar 2008 | - | $34.10 K |
FAQ
- What is Iovance Biotherapeutics annual book value?
- What is the all time high annual book value for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual book value year-on-year change?
- What is Iovance Biotherapeutics quarterly book value?
- What is the all time high quarterly book value for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly book value year-on-year change?
What is Iovance Biotherapeutics annual book value?
The current annual book value of IOVA is $710.40 M
What is the all time high annual book value for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual book value is $710.40 M
What is Iovance Biotherapeutics annual book value year-on-year change?
Over the past year, IOVA annual book value has changed by +$125.79 M (+21.52%)
What is Iovance Biotherapeutics quarterly book value?
The current quarterly book value of IOVA is $710.40 M
What is the all time high quarterly book value for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly book value is $773.45 M
What is Iovance Biotherapeutics quarterly book value year-on-year change?
Over the past year, IOVA quarterly book value has changed by $0.00 (0.00%)